Stock HCG HEALTHCARE GLOBAL ENTERPRISES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials HealthCare Global Enterprises Limited

Equities

HCG

INE075I01017

Healthcare Facilities & Services

Delayed NSE India S.E.
Other stock markets
 05:45:16 2024-05-02 am EDT 		5-day change 1st Jan Change
354.5 INR -3.16% Intraday chart for HealthCare Global Enterprises Limited -2.10% -2.85%
Mar. 08 HealthCare Global Enterprises Limited acquired remaining 49.5% stake in Hcg Eko Oncology LLP from Eko-diagnostic Pvt Ltd for INR 200 million. CI
Feb. 19 EQT, TPG and KKR Reportedly Eye Majority Stake in HCG CI

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 19,342 6,570 23,881 37,519 36,511 50,983 - -
Enterprise Value (EV) 1 24,802 12,483 27,604 44,350 43,069 56,592 55,230 52,985
P/E ratio -78 x -6.15 x -11.2 x 68 x 125 x 129 x 52.4 x 34.9 x
Yield - - - - - - - -
Capitalization / Revenue 1.98 x 0.6 x 2.36 x 2.68 x 2.15 x 2.66 x 2.35 x 2.1 x
EV / Revenue 2.53 x 1.14 x 2.72 x 3.17 x 2.54 x 2.95 x 2.54 x 2.18 x
EV / EBITDA 19.8 x 7.81 x 21.8 x 18.6 x 14.4 x 17.4 x 14 x 11.5 x
EV / FCF -27.5 x 55.9 x 32.4 x 29.8 x 36.4 x 61.8 x 30.7 x 23.9 x
FCF Yield -3.64% 1.79% 3.08% 3.36% 2.75% 1.62% 3.26% 4.18%
Price to Book 3.54 x 1.72 x 3.43 x 4.31 x 4.24 x 5.74 x 5.32 x 4.7 x
Nbr of stocks (in thousands) 87,919 88,666 125,359 139,012 139,116 139,280 - -
Reference price 2 220.0 74.10 190.5 269.9 262.4 366.0 366.0 366.0
Announcement Date 5/23/19 7/28/20 6/17/21 5/26/22 5/25/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 9,787 10,923 10,134 13,978 16,944 19,193 21,730 24,302
EBITDA 1 1,252 1,599 1,266 2,380 2,987 3,260 3,949 4,606
EBIT 1 401 114.2 -326.3 797 1,352 1,543 2,110 2,635
Operating Margin 4.1% 1.05% -3.22% 5.7% 7.98% 8.04% 9.71% 10.84%
Earnings before Tax (EBT) 1 -333.8 -1,193 -2,287 877.7 448.7 595.8 1,235 1,917
Net income 1 -248 -1,067 -1,935 537.3 293.4 398.3 928 1,401
Net margin -2.53% -9.77% -19.09% 3.84% 1.73% 2.08% 4.27% 5.77%
EPS 2 -2.820 -12.05 -17.02 3.970 2.100 2.848 6.984 10.49
Free Cash Flow 1 -902.8 223.3 851 1,489 1,184 915 1,798 2,214
FCF margin -9.22% 2.04% 8.4% 10.65% 6.98% 4.77% 8.27% 9.11%
FCF Conversion (EBITDA) - 13.97% 67.22% 62.56% 39.62% 28.07% 45.52% 48.06%
FCF Conversion (Net income) - - - 277.11% 403.37% 229.7% 193.73% 157.98%
Dividend per Share 2 - - - - - - - -
Announcement Date 5/23/19 7/28/20 6/17/21 5/26/22 5/25/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 2,740 2,980 3,231 3,520 3,581 3,646 4,080 4,200 4,247 4,417 4,607 4,799 4,886 4,961 5,213
EBITDA 1 378.4 393.6 512.3 617.4 618.6 631.5 721.6 746.9 755.1 763.2 743.1 835.2 873 872 -
EBIT 1 -39.9 9.8 134.5 237.2 204.8 220.5 324.9 338.6 347.4 341.2 333 479.6 466.6 458.6 489.3
Operating Margin -1.46% 0.33% 4.16% 6.74% 5.72% 6.05% 7.96% 8.06% 8.18% 7.72% 7.23% 9.99% 9.55% 9.24% 9.39%
Earnings before Tax (EBT) 1 -353.9 -1,044 -89.2 1,419 - - 104.2 100.2 - 131.3 105.2 293 170 216 -
Net income 1 -347.3 -1,022 -95.7 1,031 - 59.9 60.5 73.8 75.4 83.7 76.1 183.8 157.8 147 -
Net margin -12.67% -34.28% -2.96% 29.29% - 1.64% 1.48% 1.76% 1.78% 1.89% 1.65% 3.83% 3.23% 2.96% -
EPS 2 -2.330 -8.140 -0.7600 7.690 -3.550 - 0.4300 - 0.5400 0.6000 0.5400 2.070 1.940 1.425 2.250
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/11/21 6/17/21 8/12/21 11/11/21 2/10/22 5/26/22 8/10/22 11/10/22 2/9/23 5/25/23 8/10/23 - - - -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 5,460 5,913 3,723 6,830 6,558 5,609 4,247 2,002
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 4.362 x 3.698 x 2.941 x 2.87 x 2.195 x 1.721 x 1.075 x 0.4346 x
Free Cash Flow 1 -903 223 851 1,489 1,184 915 1,798 2,214
ROE (net income / shareholders' equity) -4.67% -24.9% -19.1% 6.86% 3.39% 4.35% 9.17% 11.3%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 62.10 43.00 55.60 62.60 61.90 63.80 68.80 77.90
Cash Flow per Share - - - - - - - -
Capex 1 1,888 1,078 354 712 1,332 2,070 1,442 1,450
Capex / Sales 19.29% 9.87% 3.5% 5.1% 7.86% 10.79% 6.63% 5.97%
Announcement Date 5/23/19 7/28/20 6/17/21 5/26/22 5/25/23 - - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for HealthCare Global Enterprises Limited

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
366 INR
Average target price
414.1 INR
Spread / Average Target
+13.13%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
HEALTHCARE GLOBAL ENTERPRISES LIMITED Stock HealthCare Global Enterprises Limited
-2.31% 611M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-28.69% 70.69B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+14.32% 81.84B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+9.37% 29.03B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-11.43% 16.97B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+0.64% 16.83B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-0.24% 15.28B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+6.11% 12.41B
DAVITA INC. Stock DaVita Inc.
+33.40% 12.26B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.40% 11.83B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. HCG Stock
  4. Financials HealthCare Global Enterprises Limited